Investigation of MACC1-AS1 gene mutations in colorectal cancer
Kolorektal kanserde MACC1-AS1 gen mutasyonlarının araştırılması
Abstract views: 67 / PDF downloads: 49
DOI:
https://doi.org/10.5455/GMJ-30-154367Keywords:
Colorectal cancer, DNA sequence analysis, MACC1-AS1, mutation screeningAbstract
Colorectal cancer is the frequent cause of mortality in Western world. Metastasis associated with colon cancer 1 (MACC1) gene acts as a key regulator of HGF/Met pathway and is expressed highly in colorectal cancer. MACC1 serves as a prognostic indicator for invasion and metastasis of several cancers. Potential links between MACC1 AS1 RNA locus that located in the intron 6 of MACC1 gene and high expression of MACC1 are unknown. Herein, the secondary structure of MACC-AS1 noncoding RNA and the complementarities between MACC1 mRNA and MACC1-AS1 were analyzed by RNAFold and IntaRNA programs. Since MACC1-AS1 has a proper secondary structure to hybridize with MACC1 mRNA, a potential role of MACC1-AS1 in regulation of MACC1 expression could be thought. The study included 104 controls and 96 patients. Genomic DNA was isolated from blood samples and analyzed by PCR-SSCP and sequence analysis. Three fragments and six genotypes (1, 2, 3, 1&2, 1&3, 2&3) were observed in the exon 1 of MACC1-AS1. A and GT (rs200028381) insertions in genotype 1, G>A substitution and A insertion in genotype 2 were detected. However, no association was observed between these SNPs and colorectal cancer (P>0.05). This is the first investigation on MACC1-AS1 gene mutation in colorectal cancer using molecular techniques. Novel SNPs in exon 1 were identified. In order to understand the association between colorectal tumors and MACC1-AS1 RNA expression clearly; further analysis, like Western blotting and immunohistochemistry of MACC1 and RNA analysis for MACC1-AS1, are needed.
Metrics
References
- American Cancer Society. Colorectal Cancer Facts and Figures. 2009-2011 Special, Edition 2010. Atlanta: American Cancer Society, 2010.
- American Cancer Society. Cancer Facts& Figures 2009. Atlanta: American Cancer Society; 2009. http://www.cancer.org/acs/groups/content/@nho/docum ents/document/500809webpdf.pdf Accessed on 24 March 2014.
- Jemal A, Siegel R, Ward E, Hao Y, Xu J, Thun MJ. Cancer statistics, 2009. CA Cancer J Clin 2009;59(4):225-49.
- American Cancer Society. Colorectal Cancer Facts & Figures 2011-2013. Atlanta: American Cancer Society, 2011. http://www.cancer.org/acs/groups/content/@epidemiolog ysurveilance/documents/document/acspc-028323.pdf Accessed on 24 March 2014.
- Stein U, Walther W, Arlt F, Schwabe H, Smith J, Fichtner I, et al. MACC1, a newly identified key regulator of HGF-MET signaling, predicts colon cancer metastasis. Nat Med 2009;15(1): 59-67.
- Stein U, Burock S, Herrmann P, Wendler I, Niederstrasser M, Wernecke KD, et al. Circulating MACC1 Transcripts in Colorectal Cancer Patient Plasma Predict Metastasis and Prognosis. PLoS One. 2012;7(11):e49249.
- Stein U, Dahlmann M, Walther W. MACC1-more than metastasis? Facts and predictions about a novel gene. J Mol Med (Berl) 2010;88(1):11-8.
- Zhang Y, Wang Z, Chen M, Peng L, Wang X, Ma Q, et al. MicroRNA-143 targets MACC1 to inhibit cell invasion and migration in colorectal cancer. Mol Cancer 2012;11:23.
- Stein U, Smith J, Walther W, Arlt F. MACC1 controls Met: what a difference an Sp1 site makes. Cell Cycle 2009;8(15):2467-9.
- Shirahata A, Shinmura K, Kitamura Y, Sakuraba K, Yokomizo K, Goto T, et al. MACC1 as a marker for advanced colorectal carcinoma. Anticancer Res 2010;30(7):2689-92.
- Galimi F, Torti D, Sassi F, Isella C, Corà D, Gastaldi S, et al. Genetic and expression analysis of MET, MACC1, and HGF in metastatic colorectal cancer: response to met inhibition in patient xenografts and pathologic correlations. Clin Cancer Res 2011;17(10):3146-56.
- Shirahata A, Sakata M, Kitamura Y, Sakuraba K, Yokomizo K, Goto T, et al. MACC 1 as a marker for peritonealdisseminated gastric carcinoma. Anticancer Res 2010;30(9):3441-4.
- Chundong G, Uramoto H, Onitsuka T, Shimokawa H, Iwanami T, Nakagawa M, et al. Molecular diagnosis of MACC1 status in lung adenocarcinoma by immunohistochemical analysis. Anticancer Res 2011;31(4):1141-5.
- Shimokawa H, Uramoto H, Onitsuka T, Chundong G, Hanagiri T, Oyama T, et al. Overexpression of MACC1 mRNA in lung adenocarcinoma is associated with postoperative recurrence. J Thorac Cardiovasc Surg 2011;141(4):895-8.
- Qiu J, Huang P, Liu Q, Hong J, Li B, Lu C, et al. Identification of MACC1 as a novel prognostic marker in hepatocellular carcinoma. Journal of Translational Medicine 2011;9:166.
- Shirahata A, Fan W, Sakuraba K, Yokomizo K, Goto T, Mizukami H, et al. MACC 1 as a marker for vascular invasive hepatocellular carcinoma. Anticancer Res 2011;31(3):777- 80.
- Zhang R, Shi H, Chen Z, Wu Q, Ren F, Huang H. Effects of metastasis-associated in colon cancer 1 inhibition by small hairpin RNA on ovarian carcinoma OVCAR-3cells. J Exp Clin Cancer Res 2011;30:83.
- Wang G, Kang MX, Lu WJ, Chen Y, Zhang B, Wu YL. MACC1: A potential molecule associated with pancreatic cancer metastasis and chemoresistance. Oncol Lett 2012;4(4):783- 791.
- MACC1 Antisense RNA 1, http://www.genecards.org/cgibin/ carddisp.pl?gene=MACC1-AS1&search=macc1 Accessed on 10 March 2014.
- Mattick JS, Makunin IV. Small regulatory RNAs in mammals. Hum Mol Genet 2005;14 Spec No 1:R121-32.
- Redvers RP and Anderson RL. Long noncoding RNA agent provocateur in breast cancer metastasis. In: Metastatic Cancer: integrated organ system and biological approach. Jandial R and Hunter K (eds), Landes Biosciences, 2012;pp.1-20.
- Delihas N. Regulation of gene expression by trans-encoded antisense RNAs. Mol Microbiol 1995;15(3):411-4.
- Arndt GM, Atkins D, Patrikakis M, Izant JG. Gene regulation by antisense RNA in the fission yeast Schizosaccharomyces pombe. Mol Gen Genet 1995;248(3):293-300.
- Schmid F, Burock S, Klockmeier K, Schlag PM, Stein U. SNPs in the coding region of the metastasis-inducing gene MACC1 and clinical outcome in colorectal cancer. Mol Cancer 2012;11:49.
- Lang AH, Geller-Rhomberg S, Winder T, Stark N, Gasser K, Hartmann B, et al. A common variant of the MACC1 gene is significantly associated with overall survival in colorectal cancer patients. BMC Cancer 2012;12:20.
- Qu JH, Chang XJ, Lu YY, Bai WL, Chen Y, Zhou L, et al. Overexpression of metastasis-associated in colon cancer 1 predicts a poor outcome of hepatitis B virus-related hepatocellular carcinoma. World J Gastroenterol 2012;18(23): 2995-3003.
- Kokoszyńska K, Kryński J, Rychlewski L, Wyrwicz LS. Unexpected domain composition of MACC1 links MET signaling and apoptosis. Acta Biochim Pol 2009;56(2):317- 23.
- Arlt F, Stein U. Colon cancer metastasis: MACC1 and Met as metastatic pacemakers. Int J Biochem Cell Biol 2009;41(12):2356-9.
- Kwong LN, Dove WF. APC and its modifiers in colon cancer. Adv Exp Med Biol 2009;656:85-106.
- Migliore C, Martin V, Leoni VP, Restivo A, Atzori L, Petrelli A, et al. MiR-1 downregulation cooperates with MACC1 in promoting MET overexpression in human colon cancer. Clin Cancer Res 2012;18(3):737-47.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2023 European Journal of Therapeutics
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
The content of this journal is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.